Cheng Wang, Nadira Hamid, Vinayak Bapat, Joao L Cavalcante, John R Lesser, Evan Walser-Kuntz, Larissa Stanberry, Maurice Enriquez-Sarano, Paul Sorajja
{"title":"Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.","authors":"Cheng Wang, Nadira Hamid, Vinayak Bapat, Joao L Cavalcante, John R Lesser, Evan Walser-Kuntz, Larissa Stanberry, Maurice Enriquez-Sarano, Paul Sorajja","doi":"10.1136/heartjnl-2024-325194","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tricuspid regurgitation (TR) progression following left-sided valvular heart disease (VHD) correction is a critical clinical concern. This study aimed to determine the incidence, predictors and outcomes of TR progression in a contemporary cohort.</p><p><strong>Methods: </strong>We analysed 1644 patients (mean age 73 years, 62% men) without severe TR who underwent surgical or transcatheter treatment for aortic or mitral disease between 2014 and 2018. TR progression was defined as an increase in TR grade to moderate or severe on follow-up echocardiography.</p><p><strong>Results: </strong>At 5 years, TR progression incidence was 12.0% (95% CI 10.5% to 13.7%). Baseline factors associated with TR progression included older age, female sex, atrial fibrillation, prior pacemaker implantation and larger tricuspid annular diameter (TAD). The relationship between TAD and TR progression was linear (HR 1.08; 95% CI 1.04 to 1.11; p<0.001), with sex differences mitigated by indexing TAD to body surface area. TR progression was associated with increased all-cause mortality (adjusted HR 2.77; 95% CI 2.16 to 3.56; p<0.001) and a combined endpoint of death or heart failure hospitalisation (adjusted HR 2.91; 95% CI 2.21 to 3.82; p<0.001).</p><p><strong>Conclusions: </strong>TR progression is common after left-sided VHD correction and is associated with adverse outcomes. Indexing TAD to body surface area mitigates sex differences in risk assessment. These findings suggest that lower thresholds for prophylactic tricuspid intervention may be warranted in high-risk patients.</p>","PeriodicalId":12835,"journal":{"name":"Heart","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/heartjnl-2024-325194","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Tricuspid regurgitation (TR) progression following left-sided valvular heart disease (VHD) correction is a critical clinical concern. This study aimed to determine the incidence, predictors and outcomes of TR progression in a contemporary cohort.
Methods: We analysed 1644 patients (mean age 73 years, 62% men) without severe TR who underwent surgical or transcatheter treatment for aortic or mitral disease between 2014 and 2018. TR progression was defined as an increase in TR grade to moderate or severe on follow-up echocardiography.
Results: At 5 years, TR progression incidence was 12.0% (95% CI 10.5% to 13.7%). Baseline factors associated with TR progression included older age, female sex, atrial fibrillation, prior pacemaker implantation and larger tricuspid annular diameter (TAD). The relationship between TAD and TR progression was linear (HR 1.08; 95% CI 1.04 to 1.11; p<0.001), with sex differences mitigated by indexing TAD to body surface area. TR progression was associated with increased all-cause mortality (adjusted HR 2.77; 95% CI 2.16 to 3.56; p<0.001) and a combined endpoint of death or heart failure hospitalisation (adjusted HR 2.91; 95% CI 2.21 to 3.82; p<0.001).
Conclusions: TR progression is common after left-sided VHD correction and is associated with adverse outcomes. Indexing TAD to body surface area mitigates sex differences in risk assessment. These findings suggest that lower thresholds for prophylactic tricuspid intervention may be warranted in high-risk patients.
背景:左心瓣膜病(VHD)矫正后三尖瓣反流(TR)进展是一个重要的临床问题。本研究旨在确定当代队列中TR进展的发生率、预测因素和结果。方法:我们分析了2014年至2018年间因主动脉或二尖瓣疾病接受手术或经导管治疗的1644例无严重TR患者(平均年龄73岁,男性62%)。TR进展定义为随访超声心动图显示TR等级增加至中度或重度。结果:5年时,TR进展发生率为12.0% (95% CI 10.5%至13.7%)。与TR进展相关的基线因素包括年龄较大、女性、房颤、既往植入起搏器和三尖瓣环直径较大(TAD)。TAD与TR进展呈线性关系(HR 1.08;95% CI 1.04 ~ 1.11;结论:左侧VHD矫正后TR进展是常见的,并与不良结局相关。将TAD与体表面积联系起来可以减轻风险评估中的性别差异。这些发现表明,在高危患者中,降低预防性三尖瓣干预的阈值可能是合理的。
期刊介绍:
Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access options available to authors for all articles. Education in Heart articles provide a comprehensive, continuously updated, cardiology curriculum.